Last reviewed · How we verify

NCT06144190

Discharge Criteria of Preterm Infants

Completed Last updated 22 November 2023
What this trial tests

trial in Length of Stay in 71 participants. Completed in 31 July 2022.

Timeline
1 January 2020
Primary endpoint
31 December 2021
31 July 2022

Quick facts

Lead sponsorNagano Children's Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment71
Start date1 January 2020
Primary completion31 December 2021
Estimated completion31 July 2022
Sites1 location across Japan

Conditions studied

Sponsor

Nagano Children's Hospital

Who can join

Eligibility, any sex, with Length of Stay. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This retrospective study aims to compare discharge criteria and their impact on the length of stay using two neonatal intensive care units from two countries. The possible discharge criteria include temperature control, apnea observation, periodic respiration, least weight limit, and parents' readiness. The data were collected retrospectively in each study site.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Length of Stay

Currently open trials in the same condition.

Other Nagano Children's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06144190.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing